BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17912454)

  • 1. The regulatory beta-subunit of protein kinase CK2 accelerates the degradation of CDC25A phosphatase through the checkpoint kinase Chk1.
    Kreutzer J; Guerra B
    Int J Oncol; 2007 Nov; 31(5):1251-9. PubMed ID: 17912454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase.
    Jin J; Shirogane T; Xu L; Nalepa G; Qin J; Elledge SJ; Harper JW
    Genes Dev; 2003 Dec; 17(24):3062-74. PubMed ID: 14681206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Chk1/Cdc25A pathway as activators of the cell cycle in neuronal death induced by camptothecin.
    Zhang Y; Qu D; Morris EJ; O'Hare MJ; Callaghan SM; Slack RS; Geller HM; Park DS
    J Neurosci; 2006 Aug; 26(34):8819-28. PubMed ID: 16928871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents.
    Xiao Z; Chen Z; Gunasekera AH; Sowin TJ; Rosenberg SH; Fesik S; Zhang H
    J Biol Chem; 2003 Jun; 278(24):21767-73. PubMed ID: 12676925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints.
    Zhao H; Watkins JL; Piwnica-Worms H
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14795-800. PubMed ID: 12399544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chk1 is activated transiently and targets Cdc25A for degradation at the Xenopus midblastula transition.
    Shimuta K; Nakajo N; Uto K; Hayano Y; Okazaki K; Sagata N
    EMBO J; 2002 Jul; 21(14):3694-703. PubMed ID: 12110582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of human checkpoint kinase Chk1 by the regulatory beta-subunit of protein kinase CK2.
    Guerra B; Issinger OG; Wang JY
    Oncogene; 2003 Aug; 22(32):4933-42. PubMed ID: 12902976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regulatory beta-subunit of protein kinase CK2 regulates cell-cycle progression at the onset of mitosis.
    Yde CW; Olsen BB; Meek D; Watanabe N; Guerra B
    Oncogene; 2008 Aug; 27(37):4986-97. PubMed ID: 18469858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential impact of diverse anticancer chemotherapeutics on the Cdc25A-degradation checkpoint pathway.
    Agner J; Falck J; Lukas J; Bartek J
    Exp Cell Res; 2005 Jan; 302(2):162-9. PubMed ID: 15561098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chk1-mediated Cdc25A degradation as a critical mechanism for normal cell cycle progression.
    Goto H; Natsume T; Kanemaki MT; Kaito A; Wang S; Gabazza EC; Inagaki M; Mizoguchi A
    J Cell Sci; 2019 Jan; 132(2):. PubMed ID: 30635443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Degradation of Cdc25A phosphatase in HeLa cells under normal and stress conditions].
    Goloudina AR; Aksenov ND; Pospelov VA
    Tsitologiia; 2004; 46(5):423-30. PubMed ID: 15344887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism.
    Uto K; Inoue D; Shimuta K; Nakajo N; Sagata N
    EMBO J; 2004 Aug; 23(16):3386-96. PubMed ID: 15272308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage-induced degradation of Cdc25A does not lead to inhibition of Cdk2 activity in mouse embryonic stem cells.
    Koledova Z; Kafkova LR; Krämer A; Divoky V
    Stem Cells; 2010 Mar; 28(3):450-61. PubMed ID: 20104581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CK1ε targets Cdc25A for ubiquitin-mediated proteolysis under normal conditions and in response to checkpoint activation.
    Piao S; Lee SJ; Xu Y; Gwak J; Oh S; Park BJ; Ha NC
    Cell Cycle; 2011 Feb; 10(3):531-7. PubMed ID: 21252624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T-cell leukemia virus type 1 Tax interacts with Chk1 and attenuates DNA-damage induced G2 arrest mediated by Chk1.
    Park HU; Jeong JH; Chung JH; Brady JN
    Oncogene; 2004 Jun; 23(29):4966-74. PubMed ID: 15107832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irradiation-induced G2/M checkpoint response requires ERK1/2 activation.
    Yan Y; Black CP; Cowan KH
    Oncogene; 2007 Jul; 26(32):4689-98. PubMed ID: 17297454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NEK11: linking CHK1 and CDC25A in DNA damage checkpoint signaling.
    Sørensen CS; Melixetian M; Klein DK; Helin K
    Cell Cycle; 2010 Feb; 9(3):450-5. PubMed ID: 20090422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A.
    Sørensen CS; Syljuåsen RG; Falck J; Schroeder T; Rönnstrand L; Khanna KK; Zhou BB; Bartek J; Lukas J
    Cancer Cell; 2003 Mar; 3(3):247-58. PubMed ID: 12676583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine-Threonine Kinase 38 regulates CDC25A stability and the DNA damage-induced G2/M checkpoint.
    Fukasawa T; Enomoto A; Miyagawa K
    Cell Signal; 2015 Aug; 27(8):1569-75. PubMed ID: 25936524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation.
    Yan Y; Spieker RS; Kim M; Stoeger SM; Cowan KH
    Oncogene; 2005 May; 24(20):3285-96. PubMed ID: 15735702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.